CRIO And Sitero Partner To Drive Superior Enrollment, Speed, And Quality In Phase III Trial Using eSource

In a comprehensive 2.5-year analysis involving 140 research sites across Australia, Canada, and the United States, the partnership between Sitero, a tech-enabled CRO, and CRIO's eSource platform demonstrated significant enhancements in Phase III clinical trial performance. Sites utilizing CRIO's eSource technology enrolled an average of 4.4 patients per site and achieved first-patient screening 31 days faster. Examine the partnership between CRIO and Sitero closer, including how it underscores the significant impact of technology in optimizing trial performance and accelerating the development of life-saving treatments.